divided the HCC samples into three groups for evaluating the CD8+ T-cell, including good effector function (PD-1-TIM3-), moderate exhaustion (PD-1int TIM3+) and severe exhaustion (PD-1hi TIM3+). The gene discussed is RPL17; the disease is hepatocellular carcinoma.